(E,Z)-4-<1-(p-hydroxyphenyl)-2-phenyl-1-butenyl>phenoxyacetic acid | 141777-00-6

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: (E,Z)-4-<1-(p-hydroxyphenyl)-2-phenyl-1-butenyl>phenoxyacetic acid
• 英文别名: 2-(4-(1-(4-hydroxyphenyl)-2-phenylbut-1-en-1-yl)phenoxy)acetic acid；{4-[1-(4-Hydroxyphenyl)-2-phenylbut-1-en-1-yl]phenoxy}acetic acid；2-[4-[1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenoxy]acetic acid
• CAS: 141777-00-6
• 化学式: C₂₄H₂₂O₄
• 分子量: 374.436
• InChiKey: SBXYYKVYOGLJOX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.3
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  1,1-双(4-羟基苯基)-2-苯基丁-1-烯 在 potassium carbonate 、 potassium hydroxide 作用下， 以 四氢呋喃 、 水 、 丙酮 为溶剂， 反应 4.17h， 生成 (E,Z)-4-<1-(p-hydroxyphenyl)-2-phenyl-1-butenyl>phenoxyacetic acid
  参考文献：
  名称：

  Design and Synthesis of Norendoxifen Analogues with Dual Aromatase Inhibitory and Estrogen Receptor Modulatory Activities

  摘要：

  Both selective estrogen receptor modulators and aromatase inhibitors are widely used for the treatment of breast cancer. Compounds with both aromatase inhibitory and estrogen receptor modulatory activities could have special advantages for treatment of breast cancer. Our previous efforts led to the discovery of norendoxifen as the first compound with dual aromatase inhibitory and estrogen receptor binding activities. To optimize its efficacy and aromatase selectivity versus other cytochrome P450 enzyme, a series of structurally related norendoxifen analogues were designed and synthesized. The most potent compound, 4'-hydroxynorendoxifen (10), displayed elevated inhibitory potency against aromatase and enhanced affinity for estrogen receptors when compared to norendoxifen. The selectivity of 10 for aromatase versus other cytochrome P450 eniymes was also superior to norendoxifen. 4'-Hydroxynorendoxifen is therefore an interesting lead for further development to obtain new anticancer agents of potential value for the treatment of breast cancer.

  DOI：

  10.1021/jm501218e

文献信息

• Estrogenic Triarylethylene Acetic Acids:  Effect of Structural Variation on Estrogen Receptor Affinity and Estrogenic Potency and Efficacy in MCF-7 Cells
  作者：Peter C. Ruenitz、Caryl S. Bourne、Kelly J. Sullivan、Susan A. Moore

  DOI：10.1021/jm960517e

  日期：1996.1.1

  Although a 1,1-bisphenolic analogue bearing the p-(oxyacetic acid) moiety on its 2-phenyl ring, 12, had low ER affinity, it exhibited estrogenic potency approaching that of 8 in MCF-7 cells. Unlike 8 which was a partial agonist with weak antagonist potency, 12 was a full agonist. A similar profile of potency/efficacy in MCF-7 cells was seen in 9, an ethylenic bond saturated analogue of 8. Growth-promoting

  以（E，Z）-2- 4- [1- [对羟基苯基）-2-苯基] -1-丁烯基}苯氧基乙酸（8）为例的三芳基乙烯羧酸是一类新型的雌激素受体（ER）配体组织选择性雌激素激动剂和拮抗剂的作用。我们报告8和类似物的合成，结合已知或预期可促进三芳基乙烯中的ER亲和力的结构特征。这些研究表明，对羟基苯基部分，烯键和8的醚氧对于高ER亲和力都是至关重要的。尽管在其2-苯基环12上带有对-（氧乙酸）部分的1,1-双酚类似物具有较低的ER亲和力，但在MCF-7细胞中其雌激素效价接近8。与8是拮抗作用力弱的部分激动剂不同，12是完全激动剂。在9中看到了MCF-7细胞的效价/功效的相似图谱，其是8的烯键饱和类似物。他莫昔芬抗雌激素完全拮抗了8、9和12的生长促进作用，表明这种作用是介导的。仅通过ER。因此，我们在MCF-7细胞中的研究证实了8的雌激素性，并能够鉴定出具有良好雌激素效力和完全雌激素功效的两种类似物